You are here
Home 🌿 Medical Cannabis News 🌿 GW Pharma reports high hopes for its cannabis-based drugs despite losses 🌿GW Pharma reports high hopes for its cannabis-based drugs despite losses
Warning message
The subscription service is currently unavailable. Please try again later.BRITISH drugmaker GW Pharmaceuticals yesterday posted a widened half-year, pre-tax loss, as it invested more in its cannabis-based Epidiolex treatment for childhood epilepsies.
The pharmaceutical company, dual listed on Aim in London and the Nasdaq in New York, posted a pre-tax loss of £13.7m for the six months ending March, which widened from £10.6m a year ago.
Revenue fell to £14.3m from £15m, meanwhile, as research and development costs rose from £21m to £30.5m.
However, GW Pharmaceuticals said it had raised $167.8m (£110.4m) in its offering and has high hopes for its epilepsy treatment.
Yesterday it also announced it has begun Phase III trials of Epidiolex for the treatment of Lennox-Gastaut syndrome (LGS), a rare and severe form of childhood-onset epilepsy.
Chief executive Justin Gover said new data “has only served to reinforce our confidence in the potential for Epidiolex to become an important advance in the field of treatment-resistant...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.
Follow us on Instagram
Connect with us on Linkedin